Research & Development
Research at Apotex includes the development of generic, biosimilar and innovative pharmaceuticals.
New products have been a critical component of Apotex's growth and have resulted in the development of substantial expertise in formulation development, synthetic and analytical chemistry.
Apotex has invested over $1 billion over the past ten years to develop innovative product solutions in various categories, with a projection to double that investment within the next ten years. Apotex stands among the Top 100 in Canada’s corporate R&D spending.